MYOF
Basic information
Region (hg38): 10:93306429-93482334
Previous symbols: [ "FER1L3" ]
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 18.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_013451.4 | NP_038479.1 | 54 | yes | - |
ENST00000359263.9 | ENSP00000352208.4 | 54 | yes | - |
NM_133337.3 | NP_579899.1 | 53 | - | - |
ENST00000358334.9 | ENSP00000351094.5 | 53 | - | - |
Phenotypes
GenCC
Source:
- angioedema, hereditary, 7 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Angioedema, hereditary, 7 | AD | Allergy/Immunology/Infectious | The condition can involved episodes of angioedema, and medical management may be beneficial | Allergy/Immunology/Infectious | 32542751 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (314 variants)
- not_provided (45 variants)
- MYOF-related_disorder (29 variants)
- Angioedema,_hereditary,_7 (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYOF gene is commonly pathogenic or not. These statistics are base on transcript: NM_013451.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 17 | 3 | 25 | ||
| missense | 1 | 1 | 324 | 22 | 5 | 353 |
| nonsense | 4 | 1 | 5 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
| Total | 1 | 1 | 344 | 40 | 8 |
Highest pathogenic variant AF is 0.000016728438
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MYOF | protein_coding | protein_coding | ENST00000359263 | 54 | 175889 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 124357 | 2 | 690 | 125049 | 0.00277 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.112 | 1156 | 1.17e+3 | 0.991 | 0.0000666 | 13537 |
| Missense in Polyphen | 439 | 456.57 | 0.96152 | 5398 | ||
| Synonymous | 0.279 | 430 | 437 | 0.983 | 0.0000265 | 3880 |
| Loss of Function | 2.49 | 101 | 132 | 0.766 | 0.00000743 | 1448 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00676 | 0.00674 |
| Ashkenazi Jewish | 0.00457 | 0.00458 |
| East Asian | 0.00274 | 0.00270 |
| Finnish | 0.00112 | 0.00111 |
| European (Non-Finnish) | 0.00224 | 0.00223 |
| Middle Eastern | 0.00274 | 0.00270 |
| South Asian | 0.00485 | 0.00478 |
| Other | 0.00198 | 0.00198 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium/phospholipid-binding protein that plays a role in the plasmalemma repair mechanism of endothelial cells that permits rapid resealing of membranes disrupted by mechanical stress. Involved in endocytic recycling. Implicated in VEGF signal transduction by regulating the levels of the receptor KDR (By similarity). {ECO:0000250}.;
- Pathway
- Aryl Hydrocarbon Receptor Pathway;Nuclear Receptors Meta-Pathway;Hepatitis C and Hepatocellular Carcinoma;Signaling events mediated by VEGFR1 and VEGFR2
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.0903
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.68
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.517
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- plasma membrane repair;glycerol metabolic process;muscle contraction;myoblast fusion;blood circulation;regulation of vascular endothelial growth factor receptor signaling pathway;T-tubule organization;cellular response to heat;muscle fiber development
- Cellular component
- nuclear envelope;plasma membrane;caveola;integral component of membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;nuclear membrane;intracellular membrane-bounded organelle;extracellular exosome
- Molecular function
- protein binding;phospholipid binding